

What is Qbrelis? Learn about this Lisinopril oral solution, its FDA-approved uses, proper dosage, how to take it, and important safety information for 2026.
Qbrelis is the brand name for Lisinopril oral solution, a liquid medication used to treat high blood pressure, heart failure, and to improve survival after a heart attack. It's made by Azurity Pharmaceuticals and was FDA-approved on April 29, 2016.
Unlike Lisinopril tablets (sold as Prinivil or Zestril), Qbrelis comes as a ready-to-use liquid at a concentration of 1 mg/mL in a 150 mL bottle. This makes it the go-to option for patients who cannot swallow tablets — including children, elderly patients, and anyone with swallowing difficulties (dysphagia).
Qbrelis belongs to a class of drugs called ACE inhibitors (angiotensin-converting enzyme inhibitors). To understand how it works in your body, see How Does Qbrelis Work? Mechanism of Action Explained.
Qbrelis is FDA-approved for three conditions:
Qbrelis is approved to treat high blood pressure in adults and children 6 years and older. High blood pressure is sometimes called the "silent killer" because it often has no symptoms but can lead to heart attack, stroke, and kidney damage over time. Qbrelis helps lower blood pressure to reduce these risks.
Qbrelis is used as an add-on treatment for heart failure, usually alongside diuretics and other medications. ACE inhibitors like Qbrelis help the heart pump more efficiently by reducing the workload on the heart.
In patients who are medically stable after a heart attack (acute myocardial infarction), Qbrelis can improve survival. Treatment is typically started within 24 hours of the heart attack.
Dosing depends on your condition, age, and kidney function. Always follow your doctor's instructions. Here are the typical doses:
Taking Qbrelis correctly is important for it to work properly:
Qbrelis carries the FDA's most serious warning: it can cause injury and death to an unborn baby. If you become pregnant while taking Qbrelis, stop taking it and call your doctor right away.
Do not take Qbrelis if you:
For a complete list of medications to avoid, see Qbrelis Drug Interactions. For side effect information, read Qbrelis Side Effects: What to Expect.
Qbrelis and Lisinopril tablets contain the same active ingredient. The key differences are:
| Feature | Qbrelis | Lisinopril Tablets |
|---|---|---|
| Form | Oral solution (liquid) | Tablet |
| Cost | ~$690-$800 per bottle | ~$4-$15 for 30 tablets |
| Generic available? | No generic liquid | Yes, widely available |
| Best for | Children, swallowing difficulty | Most adults |
The liquid form of Qbrelis is essential for patients who cannot take tablets. However, the much higher cost means insurance often requires prior authorization before covering it. Learn about savings options in our guide to Qbrelis coupons and discounts.
Because Qbrelis is a specialty medication, not all pharmacies carry it. Here's how to get it:
If you're having trouble finding Qbrelis, read why Qbrelis is hard to find and explore alternatives to Qbrelis. For the latest supply information, check our Qbrelis shortage update.
Qbrelis is a unique and important medication — the only FDA-approved, ready-to-use Lisinopril oral solution on the market. It's a lifeline for patients who can't swallow pills but need an ACE inhibitor for blood pressure, heart failure, or post-heart attack care.
While it can be expensive and harder to find than Lisinopril tablets, tools like MedFinder and savings programs can help. Talk to your doctor about whether Qbrelis is right for you or your child.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.